loader image
Thursday, January 8, 2026
78.1 F
McAllen
- Advertisement -

Be Cautious When Purchasing Over-the-Counter Hearing Aids

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

AUSTIN – Attorney General Ken Paxton today warned Texans to be cautious when considering buying from companies selling over-the-counter hearing aids, particularly online or by mail order. Many hearing devices sold this way are not approved by the Food and Drug Administration (FDA) and are deceptively marketed as medical hearing devices when they contain low-quality amplifiers.

Texans should remember these tips when purchasing a hearing aid:

  • Get a hearing screening and recommendation from a hearing professional who can tell you what type of hearing device will work best for you.
  • Remember that over-the-counter hearing aids are not FDA-approved. Some companies will deceptively state that they are “registered” to imply that the FDA has endorsed or approved them. It has not. 
  • Before purchasing, research the seller with the Better Business Bureau. Read online reviews and endorsements skeptically, unless you know and trust the source.

Please report suspected deceptive marketing to the Texas Attorney General’s Consumer Protection Division by calling toll-free 1-800-621-0508 or by filing an online complaint at https://www.texasattorneygeneral.gov/consumer-protection/file-consumer-complaint.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.

Historic Reset of U.S. Nutrition Policy with New Food Pyramid

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

Metabolic Trigger Identified That Shuts Down Key Tumor‑Fighting Gene

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 

MD Anderson Partners with SOPHiA GENETICS to Accelerate Innovation in AI Precision Oncology

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
- Advertisement -
×